In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes
Figure 2
Ramachandran plot of AMPK-modeled structure. Number of residues in favored region (~98.0% expected) is 422 (91.7%). Number of residues in allowed region (~2.0% expected) is 27 (5.9%). Number of residues in disallowed region is 11 (2.4%).
